Faeth Therapeutics, Inc.
FTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001829802
No open-market purchases or sales by Faeth Therapeutics, Inc. insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $333.8M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Faeth Therapeutics, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 38 | 43 | +5 |
| Shares | 3.41M | 3.55M | +146.4K (+4.3%) |
| Value | $19.7M | $8.21M | −$11.5M (−58.3%) |
New holders (11)
Institutions that held Faeth Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 83,195 | $192.0K | 0.00% |
| HighTower Advisors, LLC | 50,229 | $116.0K | 0.00% |
| Bridgeway Capital Management, LLC | 37,900 | $88.0K | 0.00% |
| BFT Financial Group, LLC | 14,845 | $34.0K | 0.01% |
| Raymond James & Associates | 13,000 | $30.0K | 0.00% |
| Jane Street Group, LLC | 10,767 | $25.0K | 0.00% |
| Barclays PLC | 3,394 | $8.00K | 0.00% |
| FNY Investment Advisers, LLC | 3,500 | $8.00K | 0.01% |
| Amalgamated Bank | 2,516 | $6.00K | 0.00% |
| Amalgamated Financial Corp. | 2,516 | $6.00K | 0.00% |
| FMR LLC | 179 | $0 | 0.00% |
Sold out (6)
Institutions that held Faeth Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Virtu Financial LLC | 15,980 | $93.0K |
| Cubist Systematic Strategies, LLC | 12,804 | $74.0K |
| Jump Financial, LLC | 11,800 | $68.0K |
| Point72 Hong Kong Ltd | 772 | $4.00K |
| Investment Research & Advisory Group, Inc. | 1,400 | $4.00K |
| Snowden Capital Advisors LLC | 200 | $1.00K |